Confirmatory Clinical Study of Treating Tricuspid Regurgitation With K-Clip TM Transcatheter Annuloplasty System - Trial NCT05173233
Access comprehensive clinical trial information for NCT05173233 through Pure Global AI's free database. This phase not specified trial is sponsored by Shanghai Huihe Medical Technology Co., Ltd and is currently Not yet recruiting. The study focuses on Tricuspid Regurgitation. Target enrollment is 67 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Shanghai Huihe Medical Technology Co., Ltd
Timeline & Enrollment
N/A
May 15, 2022
May 15, 2027
Primary Outcome
All-cause mortality,Change of Tricuspid Regurgitation Grade
Summary
The present clinical trial is performed to evaluate the effectiveness and safety of
 transcatheter tricuspid annuloplasty system manufactured by Shanghai Huihe Healthcare
 technology Co.,Ltd. for the treatment of subjects with severe or worse tricuspid
 regurgitation.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05173233
Device Trial